News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Mylan (MYL)'s Troubles Just Won't Stop Showing Up



11/7/2016 7:07:04 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
Pharmaceutical maker Mylan (MYL) is the target of yet another set of questions on its pricing practices. This time, though, its controversial autoinjector EpiPen was spared headlines.

Bloomberg and Wall Street Journal reported Thursday that the Department of Justice is investigating several generic drug makers on allegations of pricing collusion, which sent the group's stocks plummeting. The DOJ's investigation has been under way for at least two years and a number of companies have reported receiving subpoenas related to the investigation.

Read at The Street.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES